Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16709179 | 0.88 | MAOA (0.42) | MAOAMEN1POLBKMT2AGSK3B | |
| SCHEMBL1046284 | 0.86 | SMN1; SMN2 (0.38) | MAOAMEN1POLBKMT2AGSK3B | |
| SCHEMBL30702419 | 0.86 | SMN1; SMN2 (0.38) | MAOAMEN1POLBKMT2AGSK3B | |
| Iodide SCHEMBL8924984 | 0.85 | SMN1; SMN2 (0.37) | MAOAMEN1POLBKMT2AGSK3B | |
| SCHEMBL1049071 | 0.83 | POLB (0.40) | MAOAMEN1POLBKMT2AGSK3B | |
| SCHEMBL9433695 | 0.82 | GSK3B (0.43) | MAOAMEN1POLBKMT2AGSK3B | |
| SCHEMBL17151521 | 0.82 | MEN1 (0.40) | MAOAMEN1POLBKMT2AGSK3B | |
| SCHEMBL7534194 | 0.82 | MAOA (0.37) | MAOAMEN1POLBKMT2AGSK3B | |
| SCHEMBL21803243 | 0.82 | GSK3B (0.44) | GSK3BKDM1APPARGSMN1; SMN2 | |
| Iodide SCHEMBL28993212 | 0.80 | GSK3B (0.43) | GSK3BKDM1APPARGSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9929361-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-27 | — | — | US | disclosed |
| US-20160240799-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-08-18 | — | — | US | disclosed |
| US-20160240799-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-08-18 | — | — | US | disclosed |
| US-9306179-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-04-05 | — | — | US | disclosed |
| US-20150129840-A1 | OSMIUM COMPLEXES COMPRISING THREE DIFFERENT BIDENTATE LIGANDS AND METHOD OF MAKING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2015-05-14 | — | — | US | disclosed |
| US-20150129840-A1 | OSMIUM COMPLEXES COMPRISING THREE DIFFERENT BIDENTATE LIGANDS AND METHOD OF MAKING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160240799-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP2 | MAOA 2479/4885MEN1 1367/4885POLB 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.